Follow The Filings

JLL Jones Lang Lasalle Inc.

Real Estate, filed as JONES LANG LASALLE INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2, sold by 3

  • 6 Owners
  • #206
  • Max 3.3%
  • Master 0.03%
  • $496M
  • 1 add 2 reduce 1 exit 3 small

In 2026 Q2 Sarah Ketterer added to Jones Lang Lasalle, Vulcan Value Partners and Ron Baron trimmed, and First Eagle Investment Management sold out.

Who owns this now

Largest portfolio weights among holders, up to 3.3% (John Rogers, Ariel Investments). Not free-float ownership.

  1. John Rogers Add 3.3%
  2. Third Avenue Management Reduce 1.6%
  3. Vulcan Value Partners Reduce 0.91%
  4. Sarah Ketterer Add 0.83%
  5. Ron Baron Reduce 0.07%
  6. Christopher Davis Reduce 0.02%

Who owns JLL

Sorted by value, long equity only, as of 2026 Q2.

History
John Rogers, Ariel Investments 3.3% Small add +3.5% 1,060,265 $329M History
Sarah Ketterer, Causeway Capital Management 0.83%, was 0.69% Add +33.3% 248,252 $77M History
Ron Baron, Bamco Inc. (Baron Capital) 0.07%, was 0.22% Reduce −37.4% 151,040 $47M History
Vulcan Value Partners 0.91% Reduce −12.1% 96,258 $30M History
Third Avenue Management 1.6%, was 1.6% Small trim −1.1% 32,053 $9.9M History
Christopher Davis, Davis Selected Advisers 0.02% Small trim −0.8% 12,295 $3.8M History
First Eagle Investment Management exited 2026 Q2 Last 2026 Q1 <0.01% Exit 0.00% 14 $4K History

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by JLL's executives, directors and 10% owners in the last 12 months, from their Form 4s

All JLL insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • $16.3M sold by 4 insiders under 10b5-1 plans
  1. Christian Ulbrich CEO
    Planned sale
    $774K 2,000 shares at $386.99 1.4% of stake
    Traded Aug 21 Filed Aug 21
  2. Christian Ulbrich CEO
    Planned sale
    $1.5M 4,000 shares at $380.35 2.8% of stake
    Traded Aug 19–20 Filed Aug 20
  3. Christian Ulbrich CEO
    Planned sale
    $750K 2,000 shares at $375.00 1.4% of stake
    Traded Aug 18 Filed Aug 18
  4. Christian Ulbrich CEO
    Planned sale
    $750K 2,000 shares at $375.00 1.3% of stake
    Traded Aug 14 Filed Aug 17
  5. Larry Quinlan Director
    Planned sale
    $121K 402 shares at $301.73 8.4% of stake
    Traded Jun 12 Filed Jun 16
  6. Larry Quinlan Director
    Planned sale
    $119K 403 shares at $295.14 7.8% of stake
    Traded Jun 5 Filed Jun 8
  7. Richard Bloxam CEO, Capital Markets Services
    Planned sale
    $1.6M 5,440 shares at $296.94 100% of stake
    Traded Mar 24 Filed Mar 25
  8. Deborah H McAneny Director
    Planned sale
    $751K 2,500 shares at $300.50 14% of stake
    Traded Mar 10 Filed Mar 11
  9. Christian Ulbrich CEO
    Planned sale
    $1.7M 5,096 shares at $330.89 4.3% of stake
    Traded Dec 10–11 Filed Dec 12, 2025
  10. Christian Ulbrich CEO
    Planned sale
    $1.5M 4,664 shares at $330.36 3.7% of stake
    Traded Dec 5, 2025 Filed Dec 8, 2025
  11. Christian Ulbrich CEO
    Planned sale
    $3.3M 10,000 shares at $330.59 7.4% of stake
    Traded Dec 3–4 Filed Dec 5, 2025
  12. Christian Ulbrich CEO
    Planned sale
    $1.7M 5,240 shares at $331.16 3.8% of stake
    Traded Nov 26–28 Filed Dec 1, 2025
  13. Christian Ulbrich CEO
    Planned sale
    $1.7M 5,000 shares at $330.33 3.5% of stake
    Traded Nov 25, 2025 Filed Nov 26, 2025

Also filed in the last 12 months, not counted as buying or selling: 39 stock grants, 28 share withholdings for taxes, and 21 option exercises.

Congress

1 member of Congress traded JLL in the last three years: 6 buys and 7 sales. 1 member listed it in 2025 annual reports.

All Congress trades
  1. April McClain Delaney D-MD-6Child Sell $1K–$15K Mar 13 filed Apr 6
  2. April McClain Delaney D-MD-6Child Partial sale $1K–$15K Mar 3 filed Apr 6
  3. April McClain Delaney D-MD-6Child Partial sale $1K–$15K Feb 27 filed Mar 10
  4. April McClain Delaney D-MD-6Child Partial sale $1K–$15K Feb 24 filed Mar 10
  5. April McClain Delaney D-MD-6Child Partial sale $1K–$15K Feb 23 filed Mar 10
  6. April McClain Delaney D-MD-6Child Partial sale $1K–$15K Feb 18 filed Mar 10

SEC filings

Recent issuer filings from EDGAR, 12 shown.

Filed Form Detail Links
8-K 8.01
10-Q
8-K 2.02,9.01
8-K 5.02
8-K 5.02,7.01,9.01
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
8-K 5.07
SCHEDULE 13G —
8-K 2.02,9.01
10-Q

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $20.76B $23.43B $26.12B
Net income $225.4M $546.8M $792.1M
Net margin * 1.1% 2.3% 3.0%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $6.86B $7.48B $8.18B
Total non-current assets * $9.21B $9.29B $9.62B
Total assets $16.06B $16.76B $17.8B
Total current liabilities $6.45B $7.14B $7.39B
Total non-current liabilities * $3.21B $2.72B $2.79B
Total equity $6.29B $6.77B $7.5B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $0.576B $0.785B $1.19B
Cash from investing -$290.4M -$316.8M -$336.6M
Cash from financing -$374.3M -$451.2M -$643.2M
Net change in cash -$82.6M -$10.7M $246.2M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.